Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Lin

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Kidney International|March 29, 2024
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathyRichard Lafayette, Sean Barbour, Rubeen Israni, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|August 18, 2022
[Analysis on infection risk in secondary close contacts of COVID-19 patients]B Yi, Y R Chu, Y Chen, et al.
The Lancet. Respiratory Medicine|September 1, 2020
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trialDinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 16, 2019
Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over groupJ P Bilezikian, C J F Lin, J P Brown, et al.
Open Forum Infectious Diseases|January 13, 2022
Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019 Pneumonia: A Randomized Clinical TrialPrincy N Kumar, Jules Hernández-Sánchez, Sandra Nagel, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 24, 2015
The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension studyS Papapoulos, K Lippuner, C Roux, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|April 16, 2025
[Severity of SARS-CoV-2 infection in children with kidney disease undergoing immunosuppressive therapy]Y F Zhang, H H Yang, J Huang, et al.
Annals of the Rheumatic Diseases|October 26, 2017
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)Dinesh Khanna, Christopher P Denton, Celia J F Lin, et al.
Epidemiology and Infection|May 29, 2014
Seroprevalence of severe fever with thrombocytopenia syndrome virus in southeastern China and analysis of risk factorsJ M Sun, Y J Zhang, Z Y Gong, et al.
Climacteric : the Journal of the International Menopause Society|April 8, 2011
Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese womenS-Q Lin, L-Z Sun, J-F Lin, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Kidney International|March 29, 2024
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathyRichard Lafayette, Sean Barbour, Rubeen Israni, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|August 18, 2022
[Analysis on infection risk in secondary close contacts of COVID-19 patients]B Yi, Y R Chu, Y Chen, et al.
The Lancet. Respiratory Medicine|September 1, 2020
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trialDinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 16, 2019
Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over groupJ P Bilezikian, C J F Lin, J P Brown, et al.
Open Forum Infectious Diseases|January 13, 2022
Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019 Pneumonia: A Randomized Clinical TrialPrincy N Kumar, Jules Hernández-Sánchez, Sandra Nagel, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 24, 2015
The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension studyS Papapoulos, K Lippuner, C Roux, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|April 16, 2025
[Severity of SARS-CoV-2 infection in children with kidney disease undergoing immunosuppressive therapy]Y F Zhang, H H Yang, J Huang, et al.
Annals of the Rheumatic Diseases|October 26, 2017
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)Dinesh Khanna, Christopher P Denton, Celia J F Lin, et al.
Epidemiology and Infection|May 29, 2014
Seroprevalence of severe fever with thrombocytopenia syndrome virus in southeastern China and analysis of risk factorsJ M Sun, Y J Zhang, Z Y Gong, et al.
Climacteric : the Journal of the International Menopause Society|April 8, 2011
Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese womenS-Q Lin, L-Z Sun, J-F Lin, et al.
Pageof 9